Today is July 02, 2024. All times in Eastern Daylight Time.
DEBIOPHARM ET GENOME & COMPANY CONCLUENT UN ACCORD POUR LE DÉVELOPPEMENT D’UNE FAMILLE DE CONJUGUÉS ANTICORPS-MÉDICAMENT ONCOLOGIQUES POTENTIELLEMENT « FIRST-IN-CLASS »
06/03/2024 - 08:12 AM
BUSINESS WIRE
Debiopharm and Genome & Company Reach Agreement for Potential First-In Class Oncology Antibody Drug Conjugate Family
06/03/2024 - 08:11 AM
BUSINESS WIRE
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
06/03/2024 - 08:11 AM
BUSINESS WIRE
Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer
06/03/2024 - 08:10 AM
BUSINESS WIRE
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
06/03/2024 - 08:10 AM
BUSINESS WIRE
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
06/03/2024 - 08:09 AM
BUSINESS WIRE
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
06/03/2024 - 08:08 AM
BUSINESS WIRE
Kelley Shaw Joins Alliant Employee Benefits, Will Service Diverse Southeast Client Base
06/03/2024 - 08:05 AM
BUSINESS WIRE
Hyatt’s Growth Momentum Continues With Record Global Pipeline of 129,000 Rooms
06/03/2024 - 08:04 AM
BUSINESS WIRE
Grace Science, LLC Selected by FDA to Participate in the START Pilot Program for GS-100 Gene Therapy for NGLY1 Deficiency and Announcement of the Successful Treatment of the 2nd Patient
06/03/2024 - 08:03 AM
BUSINESS WIRE
1
...
1443
1444
1445
1446
1447
1448
1449
1450
1451
1452
1453
...
1476
« Previous
Next »